| Florian von Raison |
Senior Medical Director, Neurology |
MERCK SERONO INTERNATIONAL |
| John Schulpen |
Director of Clinical Research |
SANOFI-AVENTIS |
| |
and Board Member |
Belgian Association of Pharmaceutical Physicians (BeAPP) |
| Lena Höglund |
Compliance Advice & Assurance Lead Advisor |
Astrazeneca |
| Simone Braggio |
Director of Neuroscience CEDD DMPK |
GSK |
| Jean-Michel Germain |
Global Trial Director, Europe |
Wyeth |
| Gabriel Vargas |
Biomarker Expert & Head of the CNS Clinical Biomarker Group |
Hoffmann-La Roche |
| Graeme Archer |
Director of Neurosciences Discovery Biometrics |
GSK |
| Ge Ruigt |
Senior Director Translational Medicine, Neuroscience |
Schering-Plough |
| Johannes Streffer |
Director of Experimental Medicine Europe, Neurologist |
Johnson & Johnson |
| Yves Auberson |
Head of Chemistry, Neuroscience and PET Imaging |
Novartis |
| Mark Latymer |
Associate Director Phase 3b/4 Unit; Europe & Clinical Project Manager |
Pfizer |
| Babak Boroojerdi |
Senior Director, Neurologist, Head of Movement Disorders |
UCB Pharma |
| Richard Hadden |
Chief Executive Officer |
Cytox |
| Marc Debelle |
Global Medical Affairs Director NBD/R&D Psychiatry |
Solvay Pharmaceuticals |
